Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors

The development of novel antitumor agents and accompanying biomarkers has improved survival across several tumor types. Previously, we developed recommendations for tumor-agnostic treatments in patients with solid tumors with DNA mismatch repair deficient or neurotrophic receptor tyrosine kinase fus...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishima, Saori, Naito, Yoichi, Akagi, Kiwamu, Hayashi, Naomi, Hirasawa, Akira, Hishiki, Tomoro, Igarashi, Ataru, Ikeda, Masafumi, Kadowaki, Shigenori, Kajiyama, Hiroaki, Kato, Motohiro, Kenmotsu, Hirotsugu, Kodera, Yasuhiro, Komine, Keigo, Koyama, Takafumi, Maeda, Osamu, Miyachi, Mitsuru, Nishihara, Hiroshi, Nishiyama, Hiroyuki, Ohga, Shouichi, Okamoto, Wataru, Oki, Eiji, Ono, Shigeru, Sanada, Masashi, Sekine, Ikuo, Takano, Tadao, Tao, Kayoko, Terashima, Keita, Tsuchihara, Katsuya, Yatabe, Yasushi, Yoshino, Takayuki, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390617/
https://www.ncbi.nlm.nih.gov/pubmed/37300720
http://dx.doi.org/10.1007/s10147-023-02360-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390617/
https://www.ncbi.nlm.nih.gov/pubmed/37300720
http://dx.doi.org/10.1007/s10147-023-02360-8

Ejemplares similares